Jubilant Pharmova’s step down subsidiary — Jubilant Pharma Holdings Inc (JPHI) has entered into loan agreement with Standard Chartered Bank. The agreement is for five year loan facility for repayment of existing term loan and bonds aggregating $350 million and additional tranche of $50 million for future growth capex.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.